<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="771">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 27, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04487769</url>
  </required_header>
  <id_info>
    <org_study_id>LUS-COVID</org_study_id>
    <nct_id>NCT04487769</nct_id>
  </id_info>
  <brief_title>Lung Ultrasound in COVID-19 Patients</brief_title>
  <official_title>Lung Ultrasound Score for Prediction ICU Mortality in Invasively Ventilated COVID-19 Patients-Protocol for an International Multicenter Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CHU Brugmann University Hospital-Universit√© Libre de Bruxelles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Miulli Regional Hospital, Acquaviva delle Fonti, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the prognostic performance of the RALE score with respect to the mortality in ICU
      and duration of ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The prognostic capacity of the lung ultrasound score of the first examination after invasive ventilation initiation in patients with severe COVID-19.</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Covid19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Severe COVID-19 infection under invasive ventilation who received lung ultrasound
        examination as a standard care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to an ICU participating in this study between February 1, 2020 and April 30,
             2020

          -  Confirmed with reverse transcriptase polymerase chain reaction (RT-PCR) COVID-19
             infection

          -  Having had received invasive ventilation

          -  Having had examined at least once with lung ultrasound under invasive ventilation

        Exclusion Criteria:

          -  Age &lt;18 years

          -  First examination with LUS in patients already under extracorporeal membrane
             oxygenation (ECMO) support.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Marcus J Schultz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amsterdam University Medical Centers, location 'AMC'</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charalampos Pierrakos, MD</last_name>
    <phone>+3224772111</phone>
    <email>charalampos.pierrakos@chu-brugmann.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luigi Pisani, MD</last_name>
    <email>luigipisani@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus J Schultz, professor</last_name>
      <email>marcus.j.schultz@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>David MP van Meenen, MsC</last_name>
      <email>d.m.vanmeenen@amc.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 24, 2020</study_first_submitted>
  <study_first_submitted_qc>July 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2020</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Marcus J. Schultz</investigator_full_name>
    <investigator_title>Prof. M.J.Schultz,MD,PhD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

